Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Micah Robinson"'
Publikováno v:
International Journal of Nanomedicine, Vol 2010, Iss default, Pp 581-591 (2010)
Rivka Yatuv, Micah Robinson, Inbal Dayan-Tarshish, Moshe BaruOmri Laboratories Ltd., Nes Ziona, IsraelAbstract: Hemophilia A is a rare X-linked bleeding disorder caused by lack or dysfunction of coagulation factor VIII (FVIII). Hemophilia A is treate
Externí odkaz:
https://doaj.org/article/4715a0a1ae424948968807094c17044f
Publikováno v:
International Journal of Nanomedicine
International Journal of Nanomedicine, Vol 2010, Iss default, Pp 581-591 (2010)
International Journal of Nanomedicine, Vol 2010, Iss default, Pp 581-591 (2010)
Rivka Yatuv, Micah Robinson, Inbal Dayan-Tarshish, Moshe BaruOmri Laboratories Ltd., Nes Ziona, IsraelAbstract: Hemophilia A is a rare X-linked bleeding disorder caused by lack or dysfunction of coagulation factor VIII (FVIII). Hemophilia A is treate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25e26b393f9625320f550d90c5cd0e6f
http://europepmc.org/articles/PMC2939703
http://europepmc.org/articles/PMC2939703
Autor:
Moshe Baru, Olga P. Plyushch, I. Dayan, Micah Robinson, J. Spira, Nadezhda Zozulya, A. Bleicher, Rivka Yatuv
Publikováno v:
Haemophilia. 16:910-918
Recombinant activated factor VIIa (FVIIa) is a bypassing agent used to treat bleeding episodes in haemophilia patients with inhibitors to factor VIII (FVIII) and factor IX. The pharmacological effect of FVIIa is short-lived and therefore with the rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::108e87a7085e18fc917b522ceef7c123
https://doi.org/10.1111/j.1365-2516.2010.02273.x
https://doi.org/10.1111/j.1365-2516.2010.02273.x
Publikováno v:
Haemophilia. 15:1006-1013
Summary. We have shown previously that PEGylated liposomes (PEGLip) bind recombinant FVIII (rFVIII) with high affinity and specificity. This binding resulted in a significant extension of the biological activity of rFVIII as demonstrated in animal mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8b113a67d264ae7dbfdb6230641adeb
https://doi.org/10.1111/j.1365-2516.2009.02045.x
https://doi.org/10.1111/j.1365-2516.2009.02045.x
Publikováno v:
Journal of Controlled Release. 135:44-50
We have previously shown that formulation of coagulation factor VIII and activated factor VII with PEGylated liposomes (PEGLip) results in an extension of circulation time and an increase in hemostatic efficacy. Here we identified additional proteins
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::730d132dc16996e2c415fa78817410c9
https://doi.org/10.1016/j.jconrel.2008.12.004
https://doi.org/10.1016/j.jconrel.2008.12.004
Autor:
Micah Robinson, Moshe Baru, L. Carmel‐Goren, I. Aviv, M. Goldenberg‐Furmanov, I. Dayan, Rivka Yatuv
Publikováno v:
Haemophilia. 14:476-483
Summary. Recombinant activated factor VII (rFVIIa) is an effective treatment of the haemophilia patient with inhibitors and acquired haemophilia. However, on account of its relatively short half-life (HL), achieving therapeutic efficacy with FVIIa re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80b39396fa772113f133514bf6487f15
https://doi.org/10.1111/j.1365-2516.2008.01741.x
https://doi.org/10.1111/j.1365-2516.2008.01741.x
Autor:
Micah Robinson, Amir Sharon
Publikováno v:
Current Genetics. 36:98-104
A highly efficient and reproducible procedure for the transformation of the bioherbicide Colletotrichum gloeosporioides f. sp. aeschynomene by electroporation of germinated conidia is reported. Development of the procedure involved a detailed study o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f259e968481a0885d58375e4b619718
https://doi.org/10.1007/s002940050478
https://doi.org/10.1007/s002940050478
Publikováno v:
Expert opinion on drug delivery. 7(2)
Improving the pharmacodynamics of protein drugs has the potential to improve the care and the quality of life of patients suffering from a variety of diseases.Four approaches to improve protein drugs are described: PEGylation, amino acid substitution
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::783317f2c9830ad2ca2915afa82b6a89
https://pubmed.ncbi.nlm.nih.gov/20095942
https://pubmed.ncbi.nlm.nih.gov/20095942
BTN2 gene expression in the yeast Saccharomyces cerevisiae is up-regulated in response to the deletion of BTN1, which encodes the ortholog of a human Batten disease protein. We isolated Btn2 as a Snc1 v-SNARE binding protein using the two-hybrid assa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e14e66b93c255ab0606b725d3e4feff0
https://europepmc.org/articles/PMC1800815/
https://europepmc.org/articles/PMC1800815/
Autor:
Anne Spang, Jeffrey E. Gerst, Gerald C. Johnston, Micah Robinson, Pak P. Poon, Richard A. Singer, Lois E. Murray, Christina Schindler, Rachel Kama, Galina Gabriely
Gcs1 is an Arf GTPase-activating protein (Arf-GAP) that mediates Golgi-ER and post-Golgi vesicle transport in yeast. Here we show that the Snc1,2 v-SNAREs, which mediate endocytosis and exocytosis, interact physically and genetically with Gcs1. Moreo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5720c313ad2c3ee1f76efcd65061977